| Application no. and date | 12153939.9 (espacenet) (Federated) (European Patent Register), 20080321 | | Patent/reg. no. and date | DK/EP 2508188, 20230510 | | Publication date | 20121010 | | Priority no. and date | US 896286 P, 20070322 | | EP pub. no. and date |
EP 2508188 20121010 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | 1588237 | | Inventor | TAO, Li, 1 Squibb Drive
New Brunswick, NJ 08903, US,
VATSARAJ, Nipa, 1 Squibb Drive
New Brunswick, NJ 08903, US,
WU, Yongmei, 1 Squibb Drive
New Brunswick, NJ 08903, US,
Dali, Mandar V., 339 Tammy Lane
Bridgewater, New Jersey 08807, US,
Bindra, Dilbir, 1 Squibb Drive
New Brunswick, NJ 08903, US,
Parab, Prakash V., 1 Squibb Drive
New Brunswick, NJ 08903, US,
Patel, Jatin M., 1 Squibb Drive
New Brunswick, NJ 08903, US,
Tejwani, Ravindra W., 1 Squibb Drive
New Brunswick, NJ 08903, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/70 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61P 3/10 (2006.01) | | Title | Farmaceutiske formuleringer, som indeholder dapagliflozin-propylenglycol-hydrat | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
